SS Innovations (NASDAQ: SSII) completes first robotic telesurgery from mobile unit

Rhea-AI Filing Summary

SS Innovations International, Inc. reported a technology milestone, disclosing that it successfully completed the first robotic telesurgery performed from its bus mobile robotic telesurgery unit. This procedure was announced in a company press release and highlights the use of its robotic system in a mobile, remote-surgery setting. The press release describing the event is filed as an exhibit to the report.

8-K Event Classification

2 items: 8.01, 9.01

2 items

Item 8.01 Other Events Other

Voluntary disclosure of events the company deems important to shareholders but not covered by other items.

Item 9.01 Financial Statements and Exhibits Exhibits

Financial statements, pro forma financial information, and exhibit attachments filed with this report.

Understanding 8-K Material Events →

false 0001676163 0001676163 2025-08-09 2025-08-09 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934

Date of report (Date of earliest event reported): August 9, 2025

SS INNOVATIONS INTERNATIONAL, INC.

(Exact name of registrant as specified in its charter)

Florida		001-42615		47-3478854
(State or Other Jurisdiction of Incorporation)		(Commission File Number)		(IRS Employer Identification No.)

405, 3rd Floor, iLabs Info Technology Centre Udyog Vihar, Phase III Gurugram, Haryana India		122016
(Address of Principal Executive Offices)		(Zip Code)

Registrant’s telephone number, including area code: +91 73375 53469

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each Class		Trading Symbol		Name of each exchange on which registered
Common Stock		SSII		The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

As used in this Current Report on Form 8-K (this “Current Report”), the terms “SSi,” “the Company,” “we,” “us” and “our” refer to SS Innovations International, Inc. and its subsidiaries.

Item 8.01 Other Events.

On September 9, 2025, the Company issued a press release announcing the successful completion of the first robotic telesurgery performed from the Company’s MantraM bus mobile robotic telesurgery unit.

A copy of the press release is included as Exhibit 99.1 to this Current Report.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

Exhibit No.		Description
99.1		Press Release, dated September 9, 2025
104		Cover Page Interactive Data File (embedded within the Inline XBRL document)

1

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Dated: September 9, 2025	SS INNOVATIONS INTERNATIONAL, INC.
	By:	/s/ Sudhir Srivastava
		Sudhir Srivastava, M.D.
		Chairman and Chief Executive Officer

2

FAQ

What did SSII report in this 8-K filing?

SS Innovations International, Inc. reported the successful completion of the first robotic telesurgery performed from its bus mobile robotic telesurgery unit and referenced a related press release.

Does the SSII 8-K include financial results or earnings data?

The filing focuses on a technology milestone and references a press release; it does not present financial results or earnings data.

What exhibit is attached to the SSII 8-K filing?

The filing includes Exhibit 99.1, described as a press release dated September 9, 2025, plus Exhibit 104 for the cover page interactive data file.

What technology achievement did SS Innovations International, Inc. highlight?

The company highlighted the successful completion of the first robotic telesurgery carried out from its bus mobile robotic telesurgery unit.

Where is SS Innovations International, Inc. headquartered?

The company lists its principal executive offices at 405, 3rd Floor, iLabs Info Technology Centre, Udyog Vihar Phase III, Gurugram, Haryana, India 122016.